FDA recall D-1229-2022
TMC Acquisition LLC dba Tailor Made Compounding · Class II · drug
Product
Teriparatide 226mcg/ml Injectable, 4 Pre-filled Syringes, 0.25 mL-Syringe, Refrigerate, Tailor Made Compounding
Reason for recall
Lack of Assurance of Sterility
Distribution
Nationwide USA and Puerto Rico
Key facts
- Status
- Ongoing
- Initiation date
- 2022-03-07
- Report date
- 2022-07-20
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Nicholasville, KY, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1229-2022